UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of August 2021
Commission File Number: 001-39481
PainReform Ltd.
(Translation of registrant’s name into English)
4 Bruria St. Tel Aviv, 6745442
Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On August 16, 2021, PainReform Ltd. (the “Company”) issued a press release announcing its financial results for the six months ended June 30, 2021. The Company is also publishing its unaudited condensed financial statements, as well as its operating and financial review as of June 30, 2021 and for the six months then ended. Attached hereto are the following exhibits:
99.1 | Unaudited Condensed Financial Statements as of June 30, 2021 |
99.2 | Operating and Financial Review as of June 30, 2021 and for the six months then ended |
99.3 | Press Release dated August 16, 2021 |
Exhibit Index
Exhibit No. | Description | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 16, 2021 | PAINREFORM LTD. | |
By: | /s/ Ilan Hadar | |
Ilan Hadar | ||
Chief Executive Officer |